TG Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TGTX Nasdaq 8731 https://www.tgtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TG Therapeutics Inc

Top Small-Cap Stocks for June 2023 - Jun 6th, 2023 5:13 pm
TG Therapeutics to Participate in the 2023 Jefferies Healthcare Conference - Jun 5th, 2023 11:30 am
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting - Jun 2nd, 2023 1:15 pm
TG Therapeutics Announces European Commission Approval for BRIUMVI® (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis in Adults - Jun 1st, 2023 1:15 pm
TG Therapeutics Announces Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting - May 31st, 2023 11:30 am
When Will TG Therapeutics, Inc. (NASDAQ:TGTX) Turn A Profit? - May 18th, 2023 3:05 pm
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2023 Earnings Call Transcript - May 4th, 2023 2:16 pm
TG Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference - May 4th, 2023 11:30 am
Q1 2023 TG Therapeutics Inc Earnings Call - May 2nd, 2023 2:32 am
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today - May 1st, 2023 8:28 pm
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets - May 1st, 2023 8:03 pm
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates - May 1st, 2023 12:45 pm
TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results - May 1st, 2023 11:30 am
TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update - Apr 28th, 2023 8:30 pm
TG Therapeutics Announces Issuance of Permanent J-Code for BRIUMVI® (ublituximab-xiiy) from Centers for Medicare and Medicaid Services - Apr 27th, 2023 11:30 am
3 Top Biotech Stocks Defying the Bear Market - Apr 25th, 2023 12:45 pm
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting - Apr 25th, 2023 12:00 pm
Get In Now. 7 Stocks That Are Set to Soar. - Apr 13th, 2023 7:49 pm
Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales - Apr 11th, 2023 8:07 pm
Biotech Stock Surging as Analyst Predicts Strong Sales - Apr 11th, 2023 7:20 pm